NYSEARCA:IBRN iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free IBRN Stock Alerts $24.08 +0.04 (+0.17%) (As of 05/16/2024 ET) Add Compare Share Share Today's Range$23.98▼$24.0850-Day Range$22.69▼$25.8652-Week Range$19.08▼$26.90Volume729 shsAverage Volume655 shsMarket Capitalization$3.61 millionAssets Under Management$3.61 millionDividend Yield0.06%Net Expense Ratio0.47% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get iShares Neuroscience and Healthcare ETF alerts: Email Address About iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.Read More IBRN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBRN ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive IBRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Neuroscience and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBRN Inception Date8/24/2022 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Neuro Biopharma and MedTech Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$3.61 million Average Daily Volume$0.00 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Miscellaneous Outstanding Shares150,000Beta1.06 Creation Unit50,000 Creation Fee$350.00 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. iShares Neuroscience and Healthcare ETF ExpensesTypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.54%0.51%0.51%Other Expenses0.00%0.72%0.54%0.64%0.58%Total Expense0.47%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.76%-0.55%-0.68%-0.56%Net Expense0.47%0.59%0.60%0.58%0.58% iShares Neuroscience and Healthcare ETF (IBRN) Holdings & ExposureTop 10 IBRN HoldingsNeurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 4.93%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 4.79%Cerevel Therapeutics(NASDAQ:CERE)Holding Weight: 4.66%argenx(NASDAQ:ARGX)Holding Weight: 4.59%Intra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 4.51%Axonics(NASDAQ:AXNX)Holding Weight: 4.50%PTC Therapeutics(NASDAQ:PTCT)Holding Weight: 4.50%Biogen(NASDAQ:BIIB)Holding Weight: 4.48%Xenon Pharmaceuticals(NASDAQ:XENE)Holding Weight: 4.20%Biohaven(NYSE:BHVN)Holding Weight: 3.79%IBRN Sector ExposureIBRN Industry ExposureFull Holdings Details Similar ETFsProShares Ultra Nasdaq Cybersecurity ETFNASDAQ:UCYBFirst Trust Indxx Metaverse ETFNASDAQ:ARVRAdvisorShares Alpha DNA Equity Sentiment ETFNYSEARCA:SENTiShares Breakthrough Environmental Solutions ETFNASDAQ:ETECVolshares Large Cap ETFNYSEARCA:VSL IBRN ETF - Frequently Asked Questions How have IBRN shares performed in 2024? iShares Neuroscience and Healthcare ETF's stock was trading at $26.23 at the start of the year. Since then, IBRN stock has decreased by 8.2% and is now trading at $24.0775. View the best growth stocks for 2024 here. What does IBRN invest in? iShares Neuroscience and Healthcare ETF is a equity fund issued by iShares. IBRN focuses on theme investments and follows the NYSE FactSet Global Neuro Biopharma and MedTech Index. The fund's investments total to approximately $3.61 million assets under management. What stocks does iShares Neuroscience and Healthcare ETF hold? IBRN invests in 63 holdings. Some of the stocks in their portfolio include Neurocrine Biosciences (NBIX), Sarepta Therapeutics (SRPT), Cerevel Therapeutics (CERE), argenx (ARGX), Intra-Cellular Therapies (ITCI), Axonics (AXNX), PTC Therapeutics (PTCT), Biogen (BIIB), Xenon Pharmaceuticals (XENE) and Biohaven (BHVN). What is the management fee for iShares Neuroscience and Healthcare ETF? iShares Neuroscience and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IBRN is 0.47%. How do I buy shares of iShares Neuroscience and Healthcare ETF? Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:IBRN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe ExchangeCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.